During the past decade, Uzsoki Utcai Korhaz; Onkoradiológiai Osztály conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Alliance Foundation Trials, LLC." with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Institut de Recherches Internationales Servier" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" are "Breast Cancer" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Early Breast Cancer" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" in a lesser frequency.

Most popular intervention types in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" are "Drug" (8 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Palbociclib" (3 trials), "Cisplatin" (2 trials), "Placebo" (2 trials), "Alectinib" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Uzsoki Utcai Korhaz; Onkoradiológiai Osztály, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uzsoki Utcai Korhaz; Onkoradiológiai Osztály, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".